DHCA | P | ||
---|---|---|---|
No | Yes | ||
Number of patients | 12 | 21 | |
Mean(SD)age,years | 54.41(15.43) | 47.05(13.86) | 0.62 |
Sex M/F,n(%) | 6(50%)/6(50%) | 14(67%)/7(33%) | 0.73 |
Mean (SD) BMI(kg/m2) | 22.7(4.4) | 22.5(4.8) | 0.87 |
T stage,n(%) | 0.00 | ||
T2 | 9(75%) | 1(5%) | |
T3 | 3(25%) | 15(71%) | |
T4 | 0 | 5(24%) | |
Mean(SD)tumour size,mm | 8.9(3.4) | 9.5(4.2) | 0.72 |
Metastases,n(%) | 0.35 | ||
No | 9(75%) | 17(81%) | |
Yes | 3(25%) | 4(19%) | |
Fuhrman grade,n(%) | 0.63 | ||
2 | 1(8%) | 3(14%) | |
3 | 8(67%) | 13(61%) | |
4 | 3(25%) | 5(24%) | |
ECOG PS,n(%) | 0.21 | ||
0 | 5(42%) | 14(67%) | |
1 | 6(50%) | 5(24%) | |
> 1 | 1(8%) | 2(10%) | |
Mean (SD) Serum creatinine,umol/l | 76.37(15.26) | 77.12(12.54) | 0.62 |